Table 2.
Variables | Model 1 | Model 2 | Model 3 | Model 4 |
---|---|---|---|---|
β (%95 CI) | β (%95 CI) | β (%95 CI) | β (%95 CI) | |
Lumbar bone bmd | ||||
TyG | − 0.028 (− 0.035 ~ − 0.02) | − 0.024 (− 0.031 ~ − 0.016) | − 0.009 (− 0.017 ~ 0) | − 0.008 (− 0.017 ~ 0) |
Q1 | 0(Ref) | 0(Ref) | 0(Ref) | 0(Ref) |
Q2 | 0 (− 0.013 ~ 0.013) | 0.002 (− 0.011 ~ 0.016) | 0.013 (0 ~ 0.026) | 0.014 (0.001 ~ 0.027) |
Q3 | − 0.022 (− 0.036 ~ − 0.009) | − 0.018 (− 0.032 ~ − 0.005) | 0.005 (− 0.009 ~ 0.019) | 0.006 (− 0.008 ~ 0.02) |
Q4 | − 0.051 (− 0.064 ~ − 0.038) | − 0.045 (− 0.059 ~ − 0.031) | − 0.019 (− 0.034 ~ − 0.003) | − 0.017 (− 0.033 ~ − 0.002) |
P for trend | < 0.001 | < 0.001 | 0.0096 | 0.0142 |
Total bmd | ||||
TyG | − 0.002 (− 0.007 ~ 0.004) | − 0.01 (− 0.016 ~ − 0.005) | − 0.007 (− 0.013 ~ − 0.001) | − 0.007 (− 0.012 ~ − 0.001) |
Q1 | 0(Ref) | 0(Ref) | 0(Ref) | 0(Ref) |
Q2 | 0.007 (− 0.002 ~ 0.017) | 0 (− 0.009 ~ 0.009) | 0.002 (− 0.006 ~ 0.011) | 0.003 (− 0.005 ~ 0.012) |
Q3 | 0.008 (− 0.002 ~ 0.018) | − 0.002 (− 0.011 ~ 0.008) | 0.004 (− 0.005 ~ 0.014) | 0.005 (− 0.004 ~ 0.015) |
Q4 | − 0.007 (− 0.017 ~ 0.002) | − 0.023 (− 0.033 ~ − 0.013) | − 0.017 (− 0.027 ~ − 0.007) | − 0.015 (− 0.026 ~ − 0.005) |
P for trend | 0.1732 | < 0.001 | 0.0039 | 0.007 |
Subtotal bmd | ||||
TyG | 0.009 (0.004 ~ 0.015) | − 0.005 (− 0.01 ~ − 0.001) | − 0.006 (− 0.011 ~ − 0.001) | − 0.005 (− 0.011 ~ 0) |
Q1 | 0(Ref) | 0(Ref) | 0(Ref) | 0(Ref) |
Q2 | 0.016 (0.006 ~ 0.025) | 0.003 (− 0.005 ~ 0.011) | 0.003 (− 0.005 ~ 0.011) | 0.004 (− 0.004 ~ 0.012) |
Q3 | 0.021 (0.011 ~ 0.03) | 0.004 (− 0.005 ~ 0.012) | 0.006 (− 0.003 ~ 0.014) | 0.006 (− 0.002 ~ 0.015) |
Q4 | 0.012 (0.002 ~ 0.022) | − 0.015 (− 0.024 ~ − 0.006) | − 0.014 (− 0.023 ~ − 0.005) | − 0.013 (− 0.023 ~ − 0.004) |
P for trend | 0.0081 | 0.002 | 0.0054 | 0.009 |
Model 1 was not adjusted. Model 2 was adjusted for age and gender. Model 3 was adjusted for all covariables in model 2 plus race education, moderate recreational activities, diabetes, uric acid, total calcium, serum phosphorus, waist circumference, low-density lipoprotein cholesterol, smoke status, 25-hydroxyvitamin D(25OHD). Model 4 was adjusted for all covariables in model 3 plus antihyperlipidemic agents
TyG Triglyceride-glucose index, CI Confidence interval, Ref Reference